title: Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH case-control study.
authors.forename: Karine
authors.initials: K
authors.lastname: Lacut
authors.forename: Jantien
authors.initials: J
authors.lastname: van der Maaten
authors.forename: Grégoire
authors.initials: G
authors.lastname: Le Gal
authors.forename: Géraldine
authors.initials: G
authors.lastname: Cornily
authors.forename: Dominique
authors.initials: D
authors.lastname: Mottier
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Oger
mesh_terms: D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012044:Regression Analysis; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; D001241:Aspirin